Xiaodan Lyu
China Pharmaceutical University(CN)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, Glioma Diagnosis and Treatment, Microbial Natural Products and Biosynthesis, Mitochondrial Function and Pathology
Most-Cited Works
- → Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop(2017)90 cited
- → Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism(2022)41 cited
- → MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells(2016)32 cited
- → IDH mutations associated impact on related cancer epidemiology and subsequent effect toward HIF-1α(2017)22 cited
- → A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer(2023)20 cited
- → Autophagy in cancer: The cornerstone during glutamine deprivation(2021)18 cited
- → Targeting protein arginine methyltransferases in breast cancer: Promising strategies(2025)3 cited
- → Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer(2024)3 cited
- → A Novel ASCT2 Inhibitor, C118p, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer(2022)